RSV Vac, recombinant, for intramuscular use
Administering the recombinant respiratory syncytial virus (RSV) vaccine through intramuscular injection for protection against RSV infections.
CPT code 90694 involves the intramuscular administration of the recombinant respiratory syncytial virus (RSV) vaccine, providing protection against RSV infections. This vaccine is crucial for preventing respiratory tract infections caused by RSV, especially in infants and young children. The intramuscular route of administration ensures effective delivery of the vaccine, highlighting the importance of proactive healthcare measures in safeguarding vulnerable populations against RSV-related illnesses.